ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate, 95.0%, 500mg

(6-methyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetic acid, 95.0%, 250mg

1,3-Dioxolane (stabilized with BHT)>98.0%(GC)25mL

2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

2,2-Dimethyl-1-phenylpropan-1-amine hydrochloride, 95%, 5g

4-Bromo-1H-indole-7-carboxylic acid, 95.0%, 1g

(2E)-3-[4-(benzyloxy)phenyl]-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-Methoxy-5-nitropyrimidine, 95.0%, 100mg

3-[(2,6-dichlorobenzyl)oxy]benzaldehyde, 95.0%, 250mg

7-Fluoro-3-methyl-1-benzofuran-2-carboxylic acid, 97%, 50mg

5-Iodo-1-methyl-1H-imidazole, 95.0%, 5g

Tetradecylphosphonic acid, 1 g, glass packaging

2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde, 95.0%, 25g